Kerstin N Vokinger1,2, Aaron S Kesselheim3. 1. Institute of Law, University of Zurich, Zurich, Switzerland. kerstinnoelle.vokinger@usz.ch. 2. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. kerstinnoelle.vokinger@usz.ch. 3. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Authors: Kerstin N Vokinger; Thomas J Hwang; Paola Daniore; ChangWon C Lee; Ariadna Tibau; Thomas Grischott; Thomas J Rosemann; Aaron S Kesselheim Journal: JAMA Oncol Date: 2021-09-16 Impact factor: 33.006